The first Nobel Prize in Chemistry was awarded 119 years ago, and on Wednesday for the first time in its history, two women won without having to share the prize with a man. Their groundbreaking development may shift the perception of women in scientific roles, and continue to disrupt the centuries-old mindset that women are second to men in innovation or in any field.
Dr. Jennifer Doudna, a biochemist at UC Berkeley and French researcher Dr. Emmanuelle Charpentier of the Max Planch Institute accepted the Nobel Prize in Chemistry for developing the CRISPR-Cas9 genetic scissors, a
CAMBRIDGE, Mass., Oct. 8, 2020 /PRNewswire/ — Astellas Venture Management LLC (President: Kazunori Maruyama, Ph.D., “AVM”), a wholly-owned venture capital subsidiary of Astellas Pharma Inc., and LabCentral, a launchpad for early-stage life-sciences startups, today announced AXONIS Therapeutics, Inc. and Tenza as the winners of the Astellas-sponsored “Golden Ticket Competition”. A Golden Ticket award offers entrepreneurial scientists or emerging biotechnology startups one-year usage of LabCentral’s state-of-the-art lab facility in Cambridge, Massachusetts, as well as access to Astellas’ research and development (R&D) capabilities and business leaders.
AXONIS and Tenza were chosen for the strength of the innovation in their approach, the therapeutic potential of their research and alignment of their novel technological platforms with Astellas’ research and development (R&D) Focus Areas.
“In awarding these Golden Tickets, we are reinforcing Astellas’ ongoing commitment to discovering and advancing innovative science for the potential future benefit of patients worldwide,” said Maruyama, President, AVM. “We applaud
Biocom, the association representing the life science industry of California, issued the following statement regarding the announcement that the Nobel Prize in chemistry was awarded to Jennifer Doudna, Ph.D. of the University of California, Berkeley and Emmanuelle Charpentier, Ph.D. of the Max Planck Unit for the Science of Pathogens for their discovery of the genetic scissors CRISPR/Cas9.
“Since the discovery of CRISPR/Cas9 by Drs. Doudna and Charpentier – a result of resilience, curiosity and unfettered innovation – this genome editing tool has revolutionized the field of genetics,” said Joe Panetta, president and CEO of Biocom. “Dr. Doudna is an important visionary in the Bay Area and beyond, and her recognition speaks to the booming innovation in California’s unparalleled life science industry. Drs. Doudna and Charpentier have cemented themselves as tremendous role models for all women in STEM. Without their demonstrated determination, creativity and exploratory spirit, such game-changing scientific breakthroughs and
An awful lot of time elapsed between the day Roger Penrose was walking to work in 1964 and the moment his phone rang while he was in the shower on the morning of Oct. 6, 2020. Back then, his walk was interrupted by “some strange feeling of elation,” as he told the Associated Press yesterday, about the moment he had his first glimmers of insight into the equations that would eventually make him famous. It was surely with another kind of elation that he answered his phone yesterday to learn that those same equations—which were the first to prove the existence of black holes—had earned the 89-year-old University of Oxford mathematical physicist the 2020 Nobel Prize in Physics.
Penrose was not alone alone in his delight. Also honored this year were astronomers Andrea Ghez, 55, of the University of California, Los Angeles; and Reinhard Genzel, 68, of the Max
For US astronomer Andrea Ghez, who won this year’s Nobel Physics Prize, what makes black holes so fascinating is how tricky they are to conceptualize.
If she’s asked to explain them to an average person, her standard answer is: “A black hole is an object whose pull of gravity is so intense that nothing can escape it — not even light.”
That doesn’t always satisfy people’s curiosity.
“Very few people understand what a black hole is — but I think so many people are fascinated by them,” the professor at the University of California, Los Angeles told AFP by phone after she was co-awarded this year’s prize, along with Roger Penrose of Great Britain and Reinhard Genzel of Germany.
This summer, Ghez’s team celebrated the 25th anniversary of the start of their project, using a massive telescope in Hawaii, new optical technologies and innumerable calculations to measure the supermassive black
Washington D.C., October 02, 2020 –
On Sunday, Oct. 4, during the 2020 annual meeting, the National Academy of Engineering (NAE) will present two awards for extraordinary impact on the engineering profession. The Simon Ramo Founders Award will be presented to Frances S. Ligler for her research contributions and leadership in engineering. The Arthur M. Bueche Award will be given to Arden L. Bement Jr. for his contributions to technology research, policy, and national and international cooperation.
Frances S. Ligler is the Ross Lampe Distinguished Professor of Biomedical Engineering in the Joint Department of Biomedical Engineering in the College of Engineering at North Carolina State University and the School of Medicine and College of Arts and Sciences at the University of North Carolina at Chapel Hill. Ligler is being recognized with the Simon Ramo Founders Award “for the invention and development of portable optical biosensors, service to the nation and
The Eppendorf & Science Prize for Neurobiology acknowledges the increasingly active and important role of neurobiology in advancing our understanding of the functioning of the brain and the nervous system—a quest that seems destined for dramatic expansion in the coming decades.
The 2020 prize winner and finalists are a passionate and engaged group who are carrying out fascinating work at the forefront of their respective fields. Listen in as they are interviewed by Dr. Sean Sanders, Director and Senior Editor for Custom Publishing at Science. They talk about their research and how it intersects with their personal interests, as well as the impact that the coronavirus pandemic has had on their professional lives.
This international prize, established in 2002, encourages the work of promising young neurobiologists by providing support in the early stages of their careers. It is awarded annually for
(From top left clockwise): Grace McNally, Hussain Currimbhoy, Carrie McCarthy, Dana Turken, John Hibey, Cutter Hodierdien, Molly Murphy and Thor Klein
TheWrap and the Breakthrough Prize Foundation today announced the winners of the inaugural “Heroes of Science: Breakthrough Filmmakers Challenge” – a new competition created to promote and support the development of films dedicated exclusively to science and scientists. The announcement was made at TheGrill 2020, TheWrap’s annual business conference focused on the convergence between entertainment, media and technology.
Competitors submitted a proposal for a short film about a Breakthrough Prize laureate. Each candidate was then judged by a panel of experts including filmmakers, scientists and science communicators, based on the proposal’s engagement with the laureate and their work, its characterization, creativity, clarity, accuracy and vision, as well as the filmmaker’s experience.
The six winners are: Cutter Hodierne and John Hibey (US) Dana Turken (US) Grace McNally (US) Hussain Currimbhoy
Long-time tech analyst Gene Munster believes big tech is on the cusp of a major shift: It’s becoming a stock pickers’ market.
The Loup Ventures founder and managing partner expects FAANG stocks, otherwise known as Facebook, Apple, Amazon, Netflix and Google, will fail to collectively rally like they did during most of 2020’s record run.
“There’s going to be a fracturing of the performance within FAANG,” Munster told CNBC’s “Trading Nation” on Tuesday. “Think of that group of haves being Apple, Amazon and Google, and the have nots being Netflix and Facebook.”
Munster sees the split coming down to adapting to the coronavirus — as well as evolving and thriving in a post-pandemic world.
“The companies that are the haves are ultimately going to be involved in much bigger businesses,” said Munster.
He’s most bullish on Apple’s prospects, and highlights its innovation in the health and wellness space.